Repeatability in Hyperpolarized 3-Helium With MRI

Radiation Exposure Clinical Trial

Official title: Repeatability in Hyperpolarized 3-Helium Magnetic Resonance Imaging

Status Completed

Clinical Trial Summary

The main purpose of this study is to assess and test the reproducibility and results of hyperpolarized 3-Helium gas as a contrast agent with Magnetic Resonance Imaging (MRI) of the lungs in healthy adult subjects.

Clinical Trial Description

New CT imaging techniques often expose the patient to higher doses of radiation. There is a great deal of concern about effects of medical radiation exposure on the general public and regulations are becoming stricter on the radiation doses that are allowed. One novel procedure that has been developed to evaluate the function and structure of the lung is the use of hyperpolarized gases with MRI scanners. We want to compare the lung imaging techniques that we have developed in our lab to a technique that uses hyperpolarized 3-Helium gas with MRI. This technique is free from radiation and less invasive than many lung imaging techniques. Hyperpolarized gas MRI is based on the introduction of spins into the lungs, allowing imaging to take place. The use of hyperpolarized 3-Helium has a few advantages: 1. it allows us to see the microstructure of the lungs through diffusion imaging (apparent diffusion coefficient) which correlates with the size of airways and alveolar space. 2. it allows us to see ventilation, or how air moves in the lungs, at a high resolution. 3. it is capable of ultra fast imaging which will help us assess gas flow patterns within the airways. and 4) the speed of depolarization lets us measure the partial pressure of oxygen and associated gas exchange mechanisms. ;

Related Conditions & MeSH terms

• Radiation Exposure

• NCT number: NCT03776747
• Study type: Interventional
• Source: University of Iowa
• Status: Completed
• Phase: Phase 4
• Start date: July 22, 2008
• Completion date: June 2012